Browse 534 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.
There are more than 80 autoimmune diseases, from rheumatoid arthritis and psoriasis to lupus and multiple sclerosis, and together they affect a large share of people, most of them women. In each one, the immune system mistakenly attacks the body's own tissues. Treatment has moved from broad immune suppression to medicines that block specific immune signals, and most recently to approaches that aim to reset the immune system entirely.
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: New Haven CT, Quebec, Stony Brook NY, Newark NJ,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & ResponsiveNew
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
for
AIDS-Related Diffuse Large B-cell Lymphoma,
Location: Rockville MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07649304
Phase 1, Recruiting
Active & Responsive
Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.
for
HIV, HIV Self-testing, Harm Reduction,
Location: Moncton
Sponsor: Unity Health Toronto
Sex: All
Age: 16+
Code: NCT05516069
Recruiting
Active & Responsive
Vasculitis Pregnancy Registry
for
Vasculitis, Behcet's Disease, CNS Vasculitis,
Location: Tampa FL
Sponsor: University of Pennsylvania
Sex: Female
Age: 18 - 50
Code: NCT02593565
Recruiting
Active & Responsive
SNS and PrEP Initiation and Adherence in Black SMM
for
HIV
Location: Washington DC
Sponsor: Us Helping Us, People Into Living, Inc.
Sex: Male
Age: 18+
Code: NCT05499962
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
for
Graft-Versus-Host Disease, Graft-versus-leukemia,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 60
Code: NCT00001529
Recruiting
Active & Responsive
HIV Prevention Intervention for Latino Male Couples
for
HIV
Location: Orlando FL
Sponsor: University of Central Florida
Sex: Male
Age: 18 - 70+
Code: NCT06131931
Recruiting
Active & Responsive
Leveraging Chatbot to Improve PrEP in the Southern United States
for
HIV Prevention, PrEP Awareness, PrEP Uptake
Location: Miami FL, Pembroke Pines FL, Charlotte NC, Atlanta GA
Sponsor: Yale University
Sex: Male
Age: 18+
Code: NCT05968755
Recruiting
Active & Responsive
Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)
for
oGVHD, Ocular Graft Versus Host Disease
Location: Boston MA, Beverly Hills CA
Sponsor: Regenerative Ocular Immunobiologics LLC
Sex: All
Age: 18+
Code: NCT07776210
Phase 3, Recruiting
Active & Responsive
Small Trial of Alendronate Impact on the Reservoir of HIV
for
HIV
Location: Pittsburgh PA, Columbus OH, Aurora CO, San Francisco CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 65
Code: NCT07216794
Phase 2, Recruiting
Active & Responsive
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
for
Human Papilloma Virus, Anal Dysplasia, HIV
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: Male
Age: 18 - 70
Code: NCT06624839
Phase 2, Recruiting
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for
Graves' Disease, Graves Disease
Location: New York NY, Albany NY, Raleigh NC, Fort Lauderdale FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07570316
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & Responsive
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
for
HIV, Heart Failure
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 40+
Code: NCT07105007
Recruiting
Active & Responsive
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
for
Pneumocystis, Pneumocystis Pneumonia,
Location: Montreal
Sponsor: Todd C. Lee MD MPH FIDSA
Sex: All
Age: 18 - 70+
Code: NCT04851015
Phase 3, Recruiting
Active & Responsive
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, Portland OR
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06948318
Phase 3, Recruiting
Active & Responsive
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
for
IgG4 Related Disease
Location: Boston MA, Atlanta GA
Sponsor: Acepodia Biotech, Inc.
Sex: All
Age: 18+
Code: NCT07061938
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
for
Graves Disease
Location: Montreal, Surrey
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07596849
Phase 3, Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease